Skip to main content

Table 3 Peak areas of linearity standard solutions of Dolutegravir and Lamivudine

From: An effective stability indicating RP-HPLC method for simultaneous estimation of Dolutegravir and Lamivudine in bulk and their tablet dosage form

Dolutegravir

Lamivudine

Concentration (μg/mL)

Peak area

Concentration (μg/mL)

Peak area

5

2,011,389

30

5,499,384

7.5

3,113,353

45

8,303,431

10

4,166,851

60

10,887,444

12.5

5,300,175

75

13,300,994

15

6,209,262

90

15,591,086

R2

0.9989

R2

0.9984

  1. R2 regression coefficient